ask="3.9900"
ask_size="200"
average_daily_volume="62155"
bid="3.5700"
bid_size="200"
book_value="1.4000"
change="+0.5061"
change_from_200_day_moving_average="2.6572"
change_from_50_day_moving_average="2.5848"
change_from_52_week_high="-1.1199"
change_From_52_week_low="3.0701"
change_in_percent="+16.4639%"
close="3.5801"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.3000"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="1824000"
high="4.7000"
high_52_weeks="4.7000"
last_trade_date="2/16/2017"
last_trade_price="3.5801"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.5801"
low_52_weeks="0.5100"
market_capitalization="9.59M"
moving_average_200_day="0.9230"
moving_average_50_day="0.9953"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.0000"
open="4.4000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+287.8975%"
percent_change_from_50_day_moving_average="+259.7028%"
percent_change_from_52_week_high="-23.8277%"
percent_change_from_52_week_low="+601.9804%"
previous_close="3.0740"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.1957"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.1200"
stock_exchange="NCM"
symbol="XTLB"
volume="1794809"
weeks_range_52="0.5100 - 4.7000"
